LPL Financial’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,198
Closed -$395K 3120
2017
Q3
$395K Sell
2,198
-8,538
-80% -$1.19M ﹤0.01% 2131
2017
Q2
$1.11M Buy
10,736
+36
+0.3% +$2.94K ﹤0.01% 1303
2017
Q1
$837K Buy
10,700
+490
+5% +$30.3K 0.01% 1384
2016
Q4
$469K Sell
10,210
-296
-3% -$14.5K ﹤0.01% 1797
2016
Q3
$576K Sell
10,506
-801
-7% -$44.6K 0.01% 1586
2016
Q2
$582K Sell
11,307
-14,469
-56% -$711K ﹤0.01% 1541
2016
Q1
$1.29M Buy
25,776
+2,878
+13% +$139K ﹤0.01% 1483
2015
Q4
$1.43M Buy
22,898
+10,220
+81% +$719K ﹤0.01% 1398
2015
Q3
$786K Sell
12,678
-2,389
-16% -$150K ﹤0.01% 1425
2015
Q2
$984K Buy
15,067
+817
+6% +$46.6K 0.01% 1376
2015
Q1
$793K Buy
+14,250
New +$955K ﹤0.01% 1528

LPL Financial's KITE Position: Q4 2017 in Review

LPL Financial sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 2,198 shares — an estimated $395K sold.

LPL Financial first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $1.43M in Q4 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • LPL Financial reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • LPL Financial sold 2,198 Kite Pharma, Inc. shares in Q4 2017, an estimated $395K.
  • LPL Financial first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
  • LPL Financial's Kite Pharma, Inc. position peaked at $1.43M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on LPL Financial's 13F filing for Q4 2017, filed 14 Feb 2018.